Rainbow Children's Medicare Limited reported a 33.2% year-on-year rise in consolidated revenue from operations to ₹4,699.85 million for the quarter ended June 30, 2026 (Q1FY27), driven by broad-based growth across its hospital network. Net profit after tax increased 16.2% to ₹625.40 million from ₹538.05 million in the prior year period, reflecting robust patient demand and operational expansion. The strong top-line performance was supported by significant increases in inpatient discharges and outpatient consultations, underscoring the company’s ability to scale services effectively.

The unaudited standalone and consolidated financial results were reviewed by statutory auditors S.R. Batliboi & Associates LLP and approved by the Board of Directors on July 30, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In a related personnel update, the Board approved the elevation of Anshuman Jaiswal from Group Head – Legal to Chief Legal Officer, designating him as Senior Management Personnel with immediate effect.

Financial Performance

Consolidated EBITDA stood at ₹1,346 million, up 29.9% from ₹1,036 million in Q1FY26. However, EBITDA margins contracted slightly to 28.6% from 29.4% in the year-ago period, primarily due to higher professional fees paid to doctors as patient volumes expanded. Profit before tax was ₹839.53 million, compared to ₹713.74 million in Q1FY26. PAT margins remained stable at 13.3%, down 194 basis points from 15.2% in Q1FY26.

The following table summarises key consolidated financial metrics for the quarter:

Standalone revenue from operations increased to ₹4,105.47 million. Standalone profit before tax was ₹705.41 million, compared to ₹688.20 million in the prior year period. Basic earnings per share on a standalone basis rose to ₹5.20 from ₹5.09 in the prior year period.

Operational Highlights

Operational momentum remained healthy with significant growth in key patient volume indicators. Inpatient discharges reached 26,886, up 28% from 20,992 in Q1FY26. Outpatient consultations grew 25% to 410,590, while deliveries increased 23% to 4,910. Occupancy rates improved by 103 basis points to 41.24%, supported by an increase in operational beds to 1,862 from 1,523 in the prior year period.

Strategic Developments

Subsequent to the quarter end, the company executed definitive transaction documents for a new children and women's hospital at Malad, Mumbai, through its wholly owned subsidiary Rainbow Women & Children's Hospital Private Limited. This 100-bed brownfield facility is expected to commence operations in Q1 FY28, marking Rainbow's entry into Western India. Additionally, Rainbow Children’s Medicare Limited signed a Partnership Interest and Contribution Transfer Agreement to acquire a 64% stake in Super Prime Medical Care LLP for an aggregate consideration of ₹198 million. This acquisition targets a running children's hospital in Nellore, Andhra Pradesh, with completion expected in the quarter ended September 30, 2026. The company also acquired a 50-bed brand new hospital in Guntur to strengthen its Andhra Pradesh footprint.

What the Numbers Show

The slight contraction in EBITDA margin — from 29.4% to 28.6% — alongside robust revenue growth underscores margin pressure from higher professional fees to doctors, which grew significantly year-on-year. While patient volumes are expanding rapidly, the cost structure is scaling proportionally, requiring careful management of doctor compensation relative to service pricing to sustain profitability gains. The company continues to expand its footprint with new acquisitions and hospital openings, aiming to replicate its hub-and-spoke model across new geographies. With cash and investments totaling ₹6,129 million as of June 30, 2026, the company is well-positioned to fund its ongoing capital expenditure and merger plans using internal resources.

Rainbow Childrens Medicare has announced a strategic expansion into Guntur, Andhra Pradesh, through the establishment of a new women's and children's hospital. The company disclosed on July 29, 2026, that it has executed a long-term lease for the premises, marking a move to strengthen its healthcare delivery network in the state. This initiative is designed to enhance access to specialized care while leveraging an existing infrastructure to accelerate operational timelines.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated January 30, 2026. The company stated that the leased premises comprise a newly built hospital building with requisite healthcare infrastructure. This approach allows for a faster operational ramp-up with relatively lower execution timelines and capital expenditure compared to a greenfield development. The information was submitted to the National Stock Exchange of India Limited and BSE Limited.

Project Financials and Capacity

The proposed capacity addition represents a targeted growth in the company's bed count. As of the date of disclosure, Rainbow Childrens Medicare Limited operates an existing capacity of 2,435 beds with a utilization rate of 46.3%. The new facility in Guntur will add an incremental capacity of 50 beds. The total investment required for this project is approximately ₹15 crore, which will be financed entirely through internal accruals.

Strategic Rationale

Management indicated that the Guntur facility is expected to support the company's long-term growth strategy by expanding its presence in Andhra Pradesh. The hospital will focus on specialized women's and children's healthcare services, aligning with the company's core brand identity. The utilization of an existing building rather than constructing a new one is cited as a key factor in reducing capital intensity and shortening the time to market.

What the Numbers Show

The decision to finance the ₹15 crore expansion through internal accruals suggests confidence in the company's cash flow generation capabilities without resorting to external debt or equity dilution. With existing capacity utilization standing at 46.3%, there is significant room for organic growth within the current network before the new beds come online. The addition of 50 beds represents a modest 2.05% increase in total capacity, indicating a measured, low-risk approach to geographic expansion. The focus on a specialized segment (women and children) in a tier-2 city like Guntur may offer higher margin potential compared to general hospitals, assuming demand matches supply.

The proposed capacity is expected to be commissioned by September 2026, subject to the receipt of necessary approvals and completion of construction or development activities. Shreya Mitra, Company Secretary and Compliance Officer, signed the intimation letter.